Early Access — free while we kick the tires
EdgarHawk

Slater John

Director

Director
7 filings analyzed · 1 company · Latest 2026-03-23

Companies

Company Buys Sells Direction
Thryv Holdings, Inc. THRY 9 0 Net buying

Activity

March 2026
2026-03-23 Thryv Holdings, Inc. THRY
medium
Buy
2,000 shares
$5,320
Significance 3/10

Director Slater John buys 2,000 THRY shares at $2.66; stock down -80.5% from 52-week high, cluster pattern with 2 other insiders

Slater John purchased 2,000 shares of Thryv Holdings at $2.66 on 2026-03-17, increasing his holdings by 5.2% to 40,370 shares post-transaction. The purchase occurs in a depressed price environment: the stock trades at $2.97 (current price), representing a -80.5% decline from its 52-week high of $15.22 and a -23.8% decline over the past 30 days. At the same-ticker level, Slater's prior 4 measurable trades at THRY generated negative 90-day returns (-5.5%, -11.8%, -16.3%, -16.4%), with 0 of 4 prior buys well-timed at the 90-day mark. His cross-ticker track record shows 10 prior buys with an average 90-day return of -25.2% and a 22.22% win rate. A cluster pattern is present: 2 other insiders also bought within the past 14 days, suggesting coordinated or reactive buying at depressed levels. However, the company's fundamentals show signs of stress: revenue contracted -4.8% year-over-year, net income stands at $5.7M on $201.6M annual revenue (2.8% margin), and the stock's valuation appears compressed at a P/E of 1.42.

2026-03-06 Thryv Holdings, Inc. THRY
medium
Buy
3,000 shares
$9,720
Significance 3/10

Director John Slater buys 3,000 shares of THRY at $3.24 amid cluster activity; stock down 81.2% from 52-week high, insider's prior THRY trades 0/5 well-timed at 90d.

Director John Slater purchased 3,000 shares of Thryv Holdings at $3.24 on 2026-03-04, increasing his holdings from 35,370 to 38,370 shares (+8.5%), while 2 other insiders also bought within the past 14 days (cluster pattern). The stock is currently trading at $3.18, down 81.2% from its 52-week high of $16.96 and down 24.8% over the past 30 days. Critically, Slater's prior same-ticker trade history at THRY shows 0 of 5 prior buys were well-timed at the 90-day mark, with cumulative 90-day returns ranging from -18.9% to -59.5%. His cross-ticker track record also underperforms, with an average 90-day return of -25.2% and a 22.22% win rate across 9 prior buys. The cluster activity may suggest coordinated director-level conviction, but the stock's severe decline and the insider's consistent failure to time entry points well at this ticker merit scrutiny of the company's fundamentals and the soundness of management's capital allocation decisions.

November 2025
2025-11-07 Thryv Holdings, Inc. THRY
medium
Buy
1,500 shares
$10,601
Significance 4/10

Director Slater John bought 1,500 shares of THRY at blended avg $7.07 on 2025-11-05; stock at $6.26 (-68.9% from 52-week high).

Slater John, a Director at Thryv Holdings, executed 2 purchases totaling 1,500 shares for $10,601.00 at an average price of $7.07 on 2025-11-05, increasing his holdings by +4.4% to 35,370 shares. The current price of $6.26 is 68.9% below the 52-week high and down 43.6% over the past 30 days and 51.4% over the past 90 days, reflecting severe recent volatility. However, Slater's prior trade timing at THRY has been poor: his 5 prior purchases at this ticker produced 0 well-timed outcomes at the 90-day mark, with realized 90-day returns of -18.9%, -20.5%, and -8.7% on three measurable transactions. The company is currently unprofitable on a full-year basis despite quarterly revenue of $201.6M, and faces annual revenue contraction of -10.1%. This purchase occurs within a context of persistent stock decline and a historical pattern of unsuccessful timing at this specific ticker.

September 2025
2025-09-02 Thryv Holdings, Inc. THRY
low
Buy
1,000 shares
$12,920
Significance 4/10

Director Slater John buys 1,000 shares of THRY at $12.92; stock down 38.3% from 52-week high of $20.12.

Slater John, a director at Thryv Holdings, purchased 1,000 shares at $12.92 on 2025-08-29, adding to a position of 33,870 shares post-transaction. The purchase occurs as THRY trades 38.3% below its 52-week high of $20.12 and against a backdrop of deteriorating fundamentals: the company reported annual revenue growth of -10.1% and full-year net income was negative over its most recent fiscal year. His prior trades at THRY show a weak track record, with only 1 of 4 measurable prior buys achieving positive 90-day returns, and the last three purchases (most recent at 2025-03-05) each yielded 90-day losses ranging from -18.9% to -20.5%. The timing of this new purchase four days after a buy on 2025-08-25 signals sustained exposure-building during a period of stock weakness and operational headwinds.

August 2025
2025-08-27 Thryv Holdings, Inc. THRY
medium
Buy
1,000 shares
$13,690
Significance 3/10

Director Slater John bought 1,000 shares of THRY at $13.69; stock now $13.09, down -34.9% from 52-week high.

Director Slater John purchased 1,000 shares of Thryv Holdings at $13.69 on 2025-08-25, increasing his holdings to 32,870 shares. The stock has declined to $13.09, a -34.9% retreat from its 52-week high of $20.12, though it has gained 7.2% over the prior 30 days. Slater's prior five trades at THRY show a mixed record: two purchases in February 2024 achieved positive 90-day returns of +9.8% and +9.2%, but three more recent buys in September 2024 and March 2025 each declined over 90 days, with the March purchases returning -18.9% and -20.5%. Thryv's fundamentals remain challenged, with annual revenue declining -10.1% year-over-year and the company unprofitable over its most recent full fiscal year despite recent quarterly profitability.

March 2025
2025-03-06 Thryv Holdings, Inc. THRY
medium
Buy
1,000 shares
$16,587
Significance 6/10

Director Slater John bought 1,000 shares of THRY at blended $16.59 across two March trades; stock down 30.1% from 52-week high.

Director John Slater purchased 1,000 shares (700 on 2025-03-04 at $16.53, and 300 on 2025-03-05 at $16.72) in two consecutive open-market transactions, increasing his holdings by 5.0% to 20.8K shares. The purchases occurred at $16.59 blended average, below the current price of $16.89, yet the stock trades 30.1% below its 52-week high of $24.17 and is down 8.9% over the prior 30 days. His prior trades at THRY show a 66.67% 90-day win rate, with 2 of 3 prior buys proving well-timed; however, his most recent THRY buy in 2024-09-04 declined -8.7% over 90 days, suggesting uneven execution at this ticker. The company reported negative net income of $-96.1M against revenue of $179.9M in its latest quarter, with annual revenue declining 10.1% year-over-year, underlining fundamental headwinds that warrant attention to whether this purchase reflects conviction or responds to external catalysts not evident in the filing.

September 2024
2024-09-06 Thryv Holdings, Inc. THRY
high
Buy
500 shares
$9,055
Significance 6/10

Director Slater John buys 500 THRY shares at $18.11 amid -23.7% annual revenue decline and full-year unprofitability

Slater John, a director of Thryv Holdings, purchased 500 shares at $18.11 on 2024-09-04, continuing a pattern of open-market acquisitions at this ticker (both prior trades in February 2024 showed positive 90-day returns of +7.7% and +4.0%). However, this purchase occurs against a backdrop of significant deterioration in company fundamentals: annual revenue has declined -23.7% year-over-year, and the company posted negative full-year net income despite generating $224.1M in latest-quarter revenue. The stock has fallen -27.6% from its 52-week high of $24.17, though it has recovered +8.6% over the past 30 days. The director's cross-ticker track record shows a 100% 90-day win rate on 2 prior buys, yet his same-ticker history provides only two data points, making this a modest sample for conviction assessment. The current price of $17.49—below his $18.11 entry—suggests the position is currently underwater.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access